We are live on
!
Find out more
PRNB
Principia Biopharma Inc. Common Stock
PRNB
PRNB
Delisted
PRNB was delisted on the 25th of September, 2020.
53 hedge funds and large institutions have $534M invested in Principia Biopharma Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
73% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 11
18% more funds holding
Funds holding: 45 → 53 (+8)
15% more capital invested
Capital invested by funds: $463M → $534M (+$71M)
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
Holders
53
Holders Change
+8
Holders Change %
+17.78%
% of All Funds
1.18%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
19
Increased
14
Reduced
13
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.3M |
| 3 |
BlackRock
New York
|
+$7.55M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.8M |
| 5 |
JP Morgan Chase
New York
|
+$3.46M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$3.38M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.92M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$2.41M |
| 4 |
RI
RTW Investments
New York
|
-$2.28M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$2.19M |
